Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Alex Vodenlich
CEO
alex@cellogistics.com

Message the company or request a 1:1 meeting here

Cellular Logistics, Inc. is dedicated to improving the lives of individuals who suffer from heart failure. The company’s mission is to advance myocardial reparative and regenerative therapies to treat patients with heart failure. Tandem™ HF, the company’s first product, is a patented biomaterial that has been shown to boost cell retention and engraftment of therapeutic cells in the heart. Tandem™ HF promises to enable new cell therapies to revitalize damaged heart tissue and improve outcomes for the estimated 30M patients worldwide projected to suffer from heart failure by 2030.